Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 197

1.

Defective platelet adhesion on vessel subendothelium in uremic patients.

Castillo R, Lozano T, Escolar G, Revert L, López J, Ordinas A.

Blood. 1986 Aug;68(2):337-42.

2.

Uremic plasma after infusion of desmopressin (DDAVP) improves the interaction of normal platelets with vessel subendothelium.

Escolar G, Cases A, Monteagudo J, Garrido M, Lopez J, Ordinas A, Revert L, Castillo R.

J Lab Clin Med. 1989 Jul;114(1):36-42.

PMID:
2738447
3.

High von Willebrand factor concentration compensates a relative adhesion defect in uremic blood.

Zwaginga JJ, Ijsseldijk MJ, Beeser-Visser N, de Groot PG, Vos J, Sixma JJ.

Blood. 1990 Apr 1;75(7):1498-508.

4.

Uremic platelets have a functional defect affecting the interaction of von Willebrand factor with glycoprotein IIb-IIIa.

Escolar G, Cases A, Bastida E, Garrido M, López J, Revert L, Castillo R, Ordinas A.

Blood. 1990 Oct 1;76(7):1336-40.

5.

Treatment of uremic anemia with recombinant erythropoietin also reduces the defects in platelet adhesion and aggregation caused by uremic plasma.

Zwaginga JJ, IJsseldijk MJ, de Groot PG, Kooistra M, Vos J, van Es A, Koomans HA, Struyvenberg A, Sixma JJ.

Thromb Haemost. 1991 Dec 2;66(6):638-47.

PMID:
1665596
6.

Elevated plasma glycocalicin levels and decreased ristocetin-induced platelet agglutination in hemodialysis patients.

Himmelfarb J, Nelson S, McMonagle E, Holbrook D, Benoit SE, Michelson AD, Ault K.

Am J Kidney Dis. 1998 Jul;32(1):132-8.

PMID:
9669434
7.
8.
9.

Plasma and platelet von Willebrand factor defects in uremia.

Gralnick HR, McKeown LP, Williams SB, Shafer BC, Pierce L.

Am J Med. 1988 Dec;85(6):806-10.

PMID:
3264111
10.

Multimeric pattern of plasma and platelet von Willebrand factor is normal in uremic patients.

Castaman G, Rodeghiero F, Lattuada A, La Greca G, Mannucci PM.

Am J Hematol. 1993 Dec;44(4):266-9.

PMID:
8237998
11.

Reduced platelet thromboxane formation in uremia. Evidence for a functional cyclooxygenase defect.

Remuzzi G, Benigni A, Dodesini P, Schieppati A, Livio M, De Gaetano G, Day SS, Smith WL, Pinca E, Patrignani P, Patrono C.

J Clin Invest. 1983 Mar;71(3):762-8.

13.

Plasma and platelet von Willebrand factor abnormalities in patients with uremia: lack of correlation with uremic bleeding.

Casonato A, Pontara E, Vertolli UP, Steffan A, Durante C, De Marco L, Sartorello F, Girolami A.

Clin Appl Thromb Hemost. 2001 Apr;7(2):81-6.

PMID:
11292197
15.

von Willebrand factor contained in a high purity FVIII concentrate (Fanhdi) binds to platelet glycoproteins and supports platelet adhesion to subendothelium under flow conditions.

Rivera J, Escolar G, Casamiquela R, Bravo MI, Jorquera JI, Castillo R, Ordinas A, Vicente V.

Haematologica. 1999 Jan;84(1):5-11.

16.

Human platelet adhesion to subendothelium under controlled hemodynamic conditions: a methodological approach.

Dejana E, Remuzzi A, Languino LR, Costantini V, Lauri D, Zanetti A, de Gaetano G.

Methods Find Exp Clin Pharmacol. 1985 Mar;7(3):153-9.

PMID:
4010388
17.

Characterization of 25 monoclonal antibodies to factor VIII-von Willebrand factor: relationship between ristocetin-induced platelet aggregation and platelet adherence to subendothelium.

Stel HV, Sakariassen KS, Scholte BJ, Veerman EC, van der Kwast TH, de Groot PG, Sixma JJ, van Mourik JA.

Blood. 1984 Jun;63(6):1408-15.

18.

Hemostatic abnormalities in renal disease.

Jubelirer SJ.

Am J Kidney Dis. 1985 May;5(5):219-25. Review.

PMID:
3923828
19.

Reticulated platelets in uremic patients: effect of hemodialysis and continuous ambulatory peritoneal dialysis.

Tàssies D, Reverter JC, Cases A, Escolar G, Villamor N, López-Pedret J, Castillo R, Ordinas A.

Am J Hematol. 1995 Nov;50(3):161-6.

PMID:
7485076
20.

Differential aspects of the glycoprotein Ib-von Willebrand factor axis in human and pig species.

Zurbano MJ, Escolar G, Heras M, Ordinas A, Castillo R.

Haematologica. 2000 May;85(5):514-9.

Supplemental Content

Support Center